BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Zullig LL, Williams CD, Fortune-Britt AG. Lung and colorectal cancer treatment and outcomes in the Veterans Affairs health care system. Cancer Manag Res 2015;7:19-35. [PMID: 25609998 DOI: 10.2147/CMAR.S75463] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 0.7] [Reference Citation Analysis]
Number Citing Articles
1 Becker DJ, Lee KM, Lee SY, Lynch KE, Makarov DV, Sherman SE, Morrissey CD, Kelley MJ, Lynch JA. Uptake of KRAS Testing and Anti-EGFR Antibody Use for Colorectal Cancer in the VA. JCO Precis Oncol 2021;5:PO. [PMID: 34250412 DOI: 10.1200/PO.20.00359] [Reference Citation Analysis]
2 Yang H, Li Q, Niu J, Li B, Jiang D, Wan Z, Yang Q, Jiang F, Wei P, Bai S. microRNA-342-5p and miR-608 inhibit colon cancer tumorigenesis by targeting NAA10. Oncotarget 2016;7:2709-20. [PMID: 26646451 DOI: 10.18632/oncotarget.6458] [Cited by in Crossref: 39] [Cited by in F6Publishing: 38] [Article Influence: 6.5] [Reference Citation Analysis]
3 Heiden BT, Eaton DB Jr, Chang SH, Yan Y, Schoen MW, Patel MR, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V. Comparison between Veteran and Non-Veteran Populations with Clinical Stage I Non-Small Cell Lung Cancer Undergoing Surgery. Ann Surg 2021. [PMID: 34550662 DOI: 10.1097/SLA.0000000000004928] [Reference Citation Analysis]
4 Heiden BT, Eaton DB Jr, Engelhardt KE, Chang SH, Yan Y, Patel MR, Kreisel D, Nava RG, Meyers BF, Kozower BD, Puri V. Analysis of Delayed Surgical Treatment and Oncologic Outcomes in Clinical Stage I Non-Small Cell Lung Cancer. JAMA Netw Open 2021;4:e2111613. [PMID: 34042991 DOI: 10.1001/jamanetworkopen.2021.11613] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Maiga AW, Deppen SA, Denton J, Matheny ME, Gillaspie EA, Nesbitt JC, Grogan EL. Uptake of Video-Assisted Thoracoscopic Lung Resections Within the Veterans Affairs for Known or Suspected Lung Cancer. JAMA Surg 2019;154:524-9. [PMID: 30865221 DOI: 10.1001/jamasurg.2019.0035] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 Mohapatra SS, Batra SK, Bharadwaj S, Bouvet M, Cosman B, Goel A, Jogunoori W, Kelley MJ, Mishra L, Mishra B, Mohapatra S, Patel B, Pisegna JR, Raufman JP, Rao S, Roy H, Scheuner M, Singh S, Vidyarthi G, White J. Precision Medicine for CRC Patients in the Veteran Population: State-of-the-Art, Challenges and Research Directions. Dig Dis Sci 2018;63:1123-38. [PMID: 29572615 DOI: 10.1007/s10620-018-5000-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
7 Marella HK, Saleem N, Tombazzi C. Impact of Moderate versus Deep Sedation and Trainee Participation on Adenoma Detection Rate-Analysis of a Veteran Population. Clin Endosc 2021;54:250-5. [PMID: 33317225 DOI: 10.5946/ce.2020.091] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Eaglehouse YL, Shao S, Chan W, Brown D, Manjelievskaia J, Shriver CD, Zhu K. The continuum of breast cancer care and outcomes in the U.S. Military Health System: an analysis by benefit type and care source. J Cancer Surviv 2018;12:407-16. [PMID: 29455447 DOI: 10.1007/s11764-018-0680-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]